in the pathogenesis of atherosclerosis. 20 To date, there have only been a few studies on the correlation of this polymorphism with MS and its components and the results are controversial.
We therefore analyzed the allele frequencies of the Pro12Ala polymorphism in exon B and C to T substitution in exon 6 of the PPAR gene in 792 people from the Beijing Chinese Han population and observed the frequencies of different genotypes in relation to IR and MS.
Methods

Subjects
A total of 792 subjects (mean age 49.96±13.95 years, range 15-80 years) who underwent routine health checkups or who were hypertensive patients from a hypertensive clinic from 10 May 2003 to 10 October 2005 at XuanWu Hospital, Beijing, China were enrolled. All subjects had lived in Beijing for at least 3 generations and there were no genetic relationship among them. Those with medical illnesses such as hyperthyroidism, secondary hypertension, chronic liver disease, chronic renal disease, acute infection and hematologic diseases, and those taking glucocorticoids or other medications affecting glucose metabolism were excluded from the study. Written informed consent was obtained from each participant, and the study was approval by the ethical committee.
Anthropometric Measurements and Blood Chemistry
Height, weight, waist circumference (WC), hip circumference, and systolic and diastolic blood pressures were measured in triplicate and the results were averaged. The body mass index (BMI) was calculated by dividing the weight (kg) by the height (m) squared. The waist-to-hip ratio was calculated by dividing the WC by the hip circumference. After a 12-h fast, serum fasting blood glucose (FBG), total cholesterol, triglyceride (TG), high-density lipoproteincholesterol (HDL-C) and low-density lipoprotein-cholesterol (LDL-C) levels were checked with the use of automatic biochemical equipment (7170, Hitachi, Tokyo, Japan). An immunoradiology method was adopted to measure fasting serum insulin.
Diagnosis of MS
A diagnosis of MS was made when the subject satisfied the diagnosis standards promoted by the IDF (International Diabetes Federation) for MS world-wide, which was definited in 2005. 21 The standards are: being obesity in the Chinese population, having a WC of ≥85cm for males or ≥80cm for females, and any 2 of the following: (1) raised TGs ≥150mg/dl (1.7 mmol/L) or having received a specific treatment for this lipid abnormality; (2) a reduced HDL-C of <40mg/dl (1.03 mmol/L) in males or <50 mg/dl (1.29 mmol/L) in females or having received a specific treatment for this lipid abnormality; (3) a raised blood pressure: systolic of ≥130 mmHg, a diastolic of ≥85 mmHg or having received a treatment for previously diagnosed hypertension; or (4) having a raised fasting plasma glucose: a fasting plasma glucose ≥100 mg/dl (5.6 mmol/L) or having previously being diagnosed with Type 2 diabetes.
Calculation of IR Indices
The IR indices, HOMA-IR and QUICKI, were used to evaluate IR. The formulas used were as follows: 22, 23 HOMA-IR: [fasting insulin ( U/ml) × FBG (mmol/L)]/22.5; QUICKI =1/[log {fasting plasma insulin ( U/ml)}+ log {FBG (mg/dl)}].
Genotyping of the Pro12Ala Polymorphism in Exon 2 and the C161T Polymorphism in Exon 6 of the PPAR Gene With Polymerase Chain Reaction (PCR)-RFLP
Genomic DNA was extracted from subjects' blood samples by salt fractionation. The primers used for PCR from the PPAR Pro12Ala SNP were 5'-CAAGCCCAGTCCTT-TCTGTG-3' as the forward primer; and 5'-AGTGAAGG-AATCGCTTTCCG-3' as the reverse primer. A mixture of Taq polymerase 10X buffer 2.5 l, 0.25 l Taq DNA polymerase (Takara, Kyoto, Japan), 1.5 l dNTP, 4 pmol of each primer, and 1 l of template DNA was used at a total volume of 25 l, and the mixture was amplified in PCR equipment (Hybaid Express PCR, Middlesex, England). The reaction was carried out using 35 cycles of predenaturation at 94°C for 5 min, denaturation at 94°C for 45 s, annealing at 56.3°C for 45 s, and elongation at 72°C for 30 s, followed by a post-extension at 72°C for 7 min. Electrophoresis was conducted in a 1.5% agarose gel to confirm the 237-bp PCR product, and restriction was performed by using 8 U of a HpaII enzyme at 37°C overnight. The restriction site was confirmed in a 3% agarose gel. The PP homozygote produced 2 fragments at 217 and 20 bp, the PA heterozygote produced 3 fragments at 237, 217 and 20 bp; and the AA homozygote produced 1 fragment at 237 bp, which did not splice when the HpaII restriction enzyme was used.
The primers used for PCR from the PPAR C161T SNP were 5'-CAAGACAACCTGCTACAAGC-3' as the forward primer and 5'-TTCTTGTAGATCTCCTGCAG-3' as the reverse primer. A mixture of 2.5 l Taq polymerase 10x buffer, 0.25 l Taq DNA polymerase (Takara), 1.5 l dNTP, 5 pmol of each primer, and 1 l of template DNA was used at a total volume of 25 l, and the mixture was amplified in PCR equipment (Hybaid Express PCR). The reaction was carried out using 32 cycles of predenaturation at 94°C for 3 min, denaturation at 94°C for 45 s, annealing at 57.7°C for 45 s, and elongation at 72°C for 60 s, followed by a postextension at 72°C for 5 min. Electrophoresis was conducted in a 1.5% agarose gel to confirm the 200-bp PCR product and restriction was performed using 8 U of a Eco72I restriction enzyme at 37°C overnight. The restriction site was confirmed in a 2% agarose gel. The CC homozygote produced 2 fragments at 120 and 80 bp; the CT heterozygote produced 
Statistical Analysis
Results that satisfied a normal distribution are expressed as mean ± standard deviation (SD). Those results that provided abnormal distribution data are expressed as median and quartile. Statistical analysis was performed using SPSS version 10.5. The Hardy-Weinberg equilibrium was performed using the 2 test. The Student's t-test, rank sum test and one-way analysis of variance (ANOVA) method were used to compare differences between genotype groups. Pearson's 2 test was used to compare the genotype prevalence between different groups. P values <0.05 were considered to be statistically significant.
Results
Subjects' Characteristics
Of the 792 Beijing Chinese Han subjects, the Pro12Pro genotype was present in 90.91% (720 subjects) of the population and the Pro12Ala genotype was present in 9.09% (72 subjects) of the population. There were no Ala12Ala geno- types. Allele frequencies were 0.953 for Pro allele and 0.047 for Ala allele; this is a similar rare frequency of the Ala allele in an Asian population as seen in previous studies. [24] [25] [26] Genotypic frequencies of the PPAR exon 6 C161T substitution were 62.63% (496 subjects) for CC, 33.08% (262 subjects) for CT, and 4.29% (34 subjects) for the TT genotype. The allele frequency for the C allele was 0.792 and 0.208 for the T allele, demonstrating a low T-allele frequency similar to findings in previous studies. 18, 19 Allele frequencies of the 2 genotypes satisfied the Hardy-Weinberg equilibrium. Distribution characteristics of the subjects are presented in Table 1 . There were no statistically significant differences among the genotypes in terms of age, blood pressure, BMI, WC, FBG, TG, HDL-C either Pro12Ala or C161T, however, subjects with Pro12Pro or C161C had a higher fasting insulin level and HOMA-IR. At the same time, QUICKI showed a trend of decrease (p=0.076, 0.070, respectively). The mean serum total cholesterol and TG levels were lower and the HDL-C levels were higher in P-allele carriers of the Pro12Ala polymorphism compared to non-carriers, however, this was not statistically significant (p>0.05, Table 2 ).
To see if the effects of the SNPs are associated with age, we divided the subjects into 2 groups, 1 group had subjects who were younger than 60 years of age, and the other group had subjects that were 60 years and older, and then compared the parameters that related to MS (Tables 3,4 ). For Pro12Ala, in the group aged ≥60 years, P-allele carriers had higher FIN, HOMA-IR, and QUICKI levels than non P-carriers, and there was a significant difference in terms of FIN and HOMA-IR. In the group of subjects who were aged <60 years, P carriers had higher TG and lower HDL-C levels than non-P carriers, but this did not reach statistical significant (p=0.083, 0.096). For C161T, both groups showed significantly higher FIN and a HOMA-IR level in CC carriers than in T carriers. At the same time, a higher TG level and a lower HDL-C level were shown in CC carriers compared with T carriers, especially in the group aged <60 years, but this did not reach statistical significant.
To see if the effects of the polymorphisms are associated with BMI, we divided the subjects into 3 groups, a lean group (BMI <25 kg/m 2 ), an overweight group (BMI ≥25 kg/m 2 and BMI ≤30 kg/m 2 ), and an obese group (BMI >30 kg/m 2 ). 27 We compared the genotype and allele frequency among the 3 groups by using Pearson 2 analysis (Table 5 ). There was no difference among the 3 groups in terms of both polymorphisms (p=0.093, 0.853). When we combined the obese and overweight group into 1 group, the difference became significant, p=0.035 odds ratio (OR) =1.714, 95% confidence interval (CI) (1.046-2.806) for the Pro12Ala genotype. For allele frequency, the results were p=0.040, OR =1.670, 95% CI (1.032-2.704). The obese and overweight group has a higher PA genotype and an A allele frequency. Further analysis by gender was conducted and same result was achieved for both males and females. There was no difference found in terms of C161T in genotype and allele frequency when a subanalysis was conducted.
To see if the 2 SNPs were associated with MS, we divided the subjects into 2 groups. Subjects that satisfied the MS definition were put into the MS group (Mets) and other subjects who did not were put into the non-MS group (n-Mets). We compared the genotype and allele frequency between the 2 groups by using 2 analysis (Table 6) . However, there was no difference between the 2 groups for both Pro12Ala and C161T polymorphisms (p=0.804, 0.968 respectively). We divided the subjects into 4 groups according to the combination of the 2 genotypes from each SNP; that is, Pro12Pro with CC genotype (n=482), Pro12Pro with those with a T allele (n=238), Pro12Ala with CC genotype (n=14) and Pro12Ala with those with a T allele (n=58) and compared the mean values of the insulin indices, anthropometric measurements, lipid profiles and the number of metabolic components among the groups (Table 7) . There were no differences in the variables among the different combination groups of the polymorphisms, except that the BMI of the Pro12Ala with T-allele group was significantly higher than those without an Ala allele (25.90±4.06 vs 24.75±3.60, p=0.034). The Pro12Pro genotype carriers with a CC genotype had a higher level of HOMA-IR and QUICKI than the Pro12Ala genotype carriers with a T allele, but this was not statistically significant (p=0.077, 0.082, respectively).
Discussion
PPAR is expressed predominantly in adipose tissue and is known to be a terminal determinant in adipocyte differentiation. 28 The PPAR gene spans approximately 100 kb, is located on chromosome 3p25 and is composed of 9 exons with the exons 1-6 being the common region. Three different mRNA are produced because of the different splicing and promoters that occur during transcription. 9 Their tissue distribution and affinity to a ligand are not completely the same, therefore, they might play a different role in the body. PPAR 2 is mainly expressed in adipose tissue, and has been intensively studied in relation to diabetes and IR. It is the most frequently occurring polymorphism within the unique amino-terminus of the PPAR 2 isoform, replacing proline with alanine at exon B (Pro12Ala), and was originally reported to be associated with a lower BMI and improved insulin sensitivity in a population of middle-aged and elderly Finns. 29, 30 However, conclusions from further researches studies are controversial because some studies were insufficiently powered to reliably detect the association, and therefore further investigation is still required. [11] [12] [13] [14] [15] We confirmed that the allele frequencies of the Pro12Ala polymorphism of the PPAR gene in a Chinese Han population are rare, which is similar to findings involving other populations, especially Asians. 24, 26 As there was no Ala12Ala genotype contained, we performed statistical analysis on both Pro12Pro and Pro12Ala genotypes as per the methods used in a previous study. 25 Similar to the results of previous studies, those subjects in the present study with a Pro12Ala or T allele were more insulin sensitive than those without an Ala allele or T allele. The BMI in subjects with an A allele of the Pro12Ala and who were in the T allele group was significantly higher than those without an Ala allele, suggesting the possibility that an interaction of the 2 polymorphisms in related to obesity. 18, 31 At the same time, we found that overweight and obese subjects had a higher chance of having a Pro12Ala genotype and an A allele frequency, which is different to the results found in a meta-analysis of 57 studies by Tonjes A et al. 27 Although no significant differences were observed in the prevalence of MS components according to different genotypes, the prevalence of increased insulin sensitivity in A and T allele carriers suggests the possibility of a protective effect of this polymorphism on MS.
Regarding the association of this polymorphism with the presence of MS, a study by Frederiksen et al showed that the frequency of the Ala allele was lower in an IR syndrome (IRS) group diagnosed according to the European Group for the Study of Insulin Resistance (EGIR) than those not having IRS. 32 In the present study, the results showed that subjects with a Pro12Ala genotype had lower levels of FIN and HOMA-IR, suggesting that Pro12Ala might improve insulin sensitivity. However, we failed to show whether this polymorphism had an association to MS. FBS, BMI, TG, as components of Mets, showed a trend of having lower levels in the Pro12Ala SNP group than in the Pro12Ala group, however, this did not reach statistical significance. When a subanalysis was conducted, it was found that overweight and obese subjects were more likely to have a Pro12Ala genotype and A allele frequency. There was no Ala12Ala homozygote found in our study population, which is in line with the previous studies. The functional association of this polymorphism with MS needs further investigation. 31 However, the mechanism of how a Pro12Ala polymorphism improves insulin sensitivity is uncertain; researches have shown that an A substitution causes an affinity to a peroxisome proliferators response element, which decreases gene expression to a quarter of a P allele. 30 The possible mechanism that enables the A substitution to improve insulin sensitivity might be as follows: first, proline was replaced by alanine, which led to the structural and functional modification of PPAR 2, the properly decreased function of PPAR , which in turn decreased the secretion of resistin as an adipocytokine, which inhibited insulin activity. 33 Second, decreased TG contents in lever and skeletal muscle inhibited leptin expression and improved fat burning, so that adipocytes, upregulation of insulin sensitive factor, and adiponectin inhibited obesity. 34 Finally, by changing adipocyte differentiation, decreasing secretion of FFA in adipocytes, TNF and other adipocytokines, this improved insulin sensitivity. 35 The effects of Pro12Ala polymorphism on obesity might be caused by gene-gene interactions. 36 Another polymorphism site examined in the present study, the C161T substitution in exon 6 of PPAR , is the second most common polymorphism after the Pro12Ala polymorphism; it does not lead to amino acid substitution. Since its first identification in 820 French subjects, few reports have been published concerning IR and obesity. 16, 17 In the present study, we observed significant differences in FIN, HOMA-IR according to different genotypes of C161T substitution, and CC carriers showing significantly higher levels of FIN and HOMA-IR than T carriers. However, we failed to show whether this polymorphism had any association with MS and its components. Research on C161T polymorphism and MS has just started; the definite mechanism of this polymorphism and how it improves IR is not clear. Generally speaking, a polymorphism is not necessarily associated with its functional modification. We suggest that it might produce total or almost total linkage disequilibrium with other known or unknown polymorphism sites, or might link with certain sites in the promoter region, and might produce linkage disequilibrium with sites in the intron area that are related to mRNA splicing, which would affect PPAR gene expression. Both excessive activation and appropriate down regulation of PPAR expression can improve insulin sensitivity. The former increases the contents of white adipose tissue, redistributes TG in the body and decreases TG in the lever and muscular tissue, allowing the muscle to uptake more glucose, which improves insulin sensitivity. 37 The latter might decrease leptin expression and lipid production, and at the same time might increase fatty acid burning so that there is a decrease of TG content in the lever and muscular tissue, 34 which improves insulin sensitivity. However, to confirm this hypothesis, further investigation is required.
Some reports have proposed the gene-to-gene interaction between Pro12Ala and C161T polymorphisms. 18, 19 Therefore, we subdivided the subjects into 4 groups according to the different combinations of the 2 genotypes, and analyzed the differences in parameters of MS. The subgroup with the Pro12Ala and T allele had a significantly higher BMI than those without the Ala allele, suggesting the possibility of the interaction of the 2 polymorphisms in regard to obesity, which is also in line with the previous reports; 25 however, the precise mechanism requires further research.
There are several limitations in the present study that should be mentioned. First, we adopted both HOMA-IR and QUICKI to measure the insulin-resistant status. Although the euglycemic clamp test is the standard method for measuring IR, it is complex and costly, which is why it is only used for research purposes. 38 Instead, the more convenient HOMA-IR and QUICKI tests are widely used in epidemiological and clinical studies, and these methods are known to correlate very well with clamp studies. 22, 39, 40 For the relatively large sample size in this study, it is difficult for clamp studies. Second, the possibility of linkage disequilibrium could not be distinguished by assuming simple associations between the 2 polymorphisms. We tried to explain the results in relation to the literature and knowledge we have; the exact mechanism of the association of these 2 polymorphisms and the precise mode of involvement in insulin sensitivity and atherosclerosis warrants deeper functional discoveries in the future.
In conclusion, we observed that the frequencies of the 2 most common polymorphisms of the PPAR gene in a Beijing Han population are similar to those observed in other Asian populations. The Pro12Ala and C161T polymorphisms showed significant association with IR and the presence of Pro12Ala and T allele simultaneously showed potential effect on obesity, which confirmed the gene-gene interaction in the mechanisms of Mets. At the same time, we found that overweight and obese subjects had a higher chance of having a Pro12Ala genotype and A allele frequency. However, there were no associations between the 2 SNPs and MS, suggesting that Mets is a multi-gene disease, and that gene-gene and gene-environmental interactions determine its onset. 4, 36 This possibility needs further confirmation in large, well-characterized study populations.
